Gossamer Bio's total assets for Q4 2024 were $315.29M, a decrease of -10.14% from the previous quarter. GOSS total liabilities were $285.80M for the fiscal quarter, a -3.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.